AKANDA CORP

AKANNASDAQ

🏆 #5034 by market capUS Equity

$5.33▲ $0.12 (+2.30%)

Live

1h▲ 0.0%

24h▲ 2.3%

7d▲ 0.4%

14d▼ 15.7%

30d▼ 48.6%

1y▼ 94.4%

🏦Market Cap

$172,511

Small Cap

📈Revenue Growth (YoY)

-69.2%

Declining

📊Gross Margin

-382.7%

Thin

💵FCF Margin

-3085.6%

Thin

⚖️P/S Ratio

0.7x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $5.30 – $5.41
52-Week Range: $2.30 – $209.23
Volume: $2.71B
Avg Volume: $3.22B
Shares Outstanding: 32,366
Next Earnings: Sep 26, 2026

Fundamentals Snapshot

Annual Revenue: $258,075
Last Q Revenue: $258,075
P/E Ratio: -0.0
P/S Ratio: 0.7x
EPS (TTM): $-667.05
Dividend Yield: 0.00%

Why Investors Own AKAN

✓High-growth profile — revenue up +52.6% YoY with expanding US Equity exposure.
✓Healthy economics — 70% gross margin and 30% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$258,075▲ +55.4% YoY

Gross Margin (TTM)

70.0%▲ +3.2% YoY

Operating Income (TTM)

$61,422▲ +55.4% YoY

Free Cash Flow (TTM)

$77,164▲ +55.4% YoY

About AKANDA CORP

Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.

🦦